Malignant solid tumor as follows: stage III B or IV lung cancer
Conditions
Interventions
Intervention group: Managing Cancer and Living Meaningfully (CALM) is a brief, semi structured and manualized psychotherapeutic intervention intended to treat and prevent depression and end-of-life di
changes in self and relations with close others
spiritual well-being and sense of meaning and purpose
and preparing for the future, sustaining hope, and facing mortality. The timing of sessions and content explored are guided by the patient’s interests and priorities. Interventions are adapted to pati
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Fluency in Persian language Diploma or higher level of education and living in Tehran Diagnosis of the metastatic solid tumor as follows: stage III B or IV lung cancer; any stage of pancreatic cancer, stage III or IV ovarian and fallopian tube cancers, or stage IV of other gynecological cancers; and stage IV breast, genitourinary, gastrointestinal, melanoma, sarcoma, or endocrine cancers Life expectancy 12 to 18 months A score greater than or equal10 on the Patient Health Questionnaire (PHQ9) A score greater than 5 on the Post-traumatic Stress Disorder Checklist (PCL-5) A score greater than or equal to 20 on the Death and Dying Distress Scale (DADDS) A score lesser than 27 on Mini-Mental State Examination (MMSE)
Exclusion criteria
Exclusion criteria: Language or communication barriers hindering psychotherapy Consciousness problems or inability to participate in assessment and intervention sessions Disorder and features of acute psychosis Suicidal thoughts and attempts Severe sensorimotor disabilities Brain damage or any medical condition that better explains the cognitive and psychological problems of patients with advanced cancer Concomitant psychotherapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The score of depression symptoms in the Patient Health Questionnaire (PHQ-9). Timepoint: Before starting the intervention, the third month for evaluation and the 4th month for follow-up. Method of measurement: Using the Patient Health Questionnaire (PHQ-9).;The score of death distress in the Death And Dying Distress Scale (DADDS). Timepoint: Before starting the intervention, the third month for evaluation and the 4th month for follow-up. Method of measurement: Using Death And Dying Distress Scale (DADDS).;The score of post-traumatic stress symptoms in Posttraumatic Stress Disorder Checklist (PCL-5). Timepoint: Before starting the intervention, the third month for evaluation and the 4th month for follow-up. Method of measurement: Using Posttraumatic Stress Disorder Checklist (PCL-5).;The quality of life score in the quality-of-life scale of patients with advanced cancer (QUAL-EC). Timepoint: Before starting the intervention, the third month for evaluation and the 4th month for follow-up. Method of measurement: Using Quality of life scale of patients with advanced cancer (QUAL-EC).;The memory score in the Prospective and Retrospective Memory Questionnaire (PRMQ). Timepoint: Before starting the intervention, the third month for evaluation and the 4th month for follow-up. Method of measurement: Using Prospective and Retrospective Memory Questionnaire (PRMQ). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSanaz Nabipour
The University of Kharazmi
Outcome results
None listed